Keyphrases
23-valent Pneumococcal Polysaccharide Vaccine
25%
Age Band
25%
Age Groups
37%
Age-specific Incidence
12%
Annual Incidence
12%
Developed Countries
12%
Disease Case
25%
Incidence Estimates
12%
Incidence Rate
25%
Indirect Cohort Method
25%
Invasive Pneumococcal Disease
100%
Number Needed to Vaccinate
25%
Pneumococcal Vaccination
100%
Practice-based Research Network
12%
Protective Effect
12%
Reference Laboratory
12%
Retrospective Cohort Design
12%
Risk Reduction
12%
Scotland
100%
Scottish
12%
Screening Method
12%
Sentinel
12%
Standardized Incidence Ratio
62%
Vaccination Program
12%
Vaccine Effectiveness
62%
Vaccine Uptake
12%
Winter Season
50%
Pharmacology, Toxicology and Pharmaceutical Science
Pneumococcal Infection
100%
Pneumococcus Vaccine
25%
Polysaccharide
25%
Standardized Incidence Ratio
62%
Vaccination Policy
100%
Agricultural and Biological Sciences
Annuals
50%
Polysaccharide
100%
Protective Effect
50%